TILT Biotherapeutics

Theolytics

The company develops oncolytic viral immunotherapies for patients with solid tumours.

Xilio Therapeutics

This biotechnology company develops tumour-activated immuno-oncology therapies designed to treat patients with solid cancers while reducing systemic side effects.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.

Stratosvir

This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.

Oncorus

This company develops intravenous self-amplifying RNA medicines and viral immunotherapies for patients with solid tumours.

Abalos Therapeutics

This company develops arenavirus-based immuno-virotherapies to treat solid tumours and metastases for patients with cancer.

OverT

This biotechnology company develops engineered cell therapies for the treatment of solid tumours in cancer patients.

Bolt Biotherapeutics

This company develops immune-stimulating antibody conjugate therapies to treat patients with solid tumours by activating the innate and adaptive immune systems.